-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Buy on Alkermes, Raises Price Target to $48

Benzinga·05/06/2026 21:18:13
Listen to the news
UBS analyst Ashwani Verma maintains Alkermes (NASDAQ:ALKS) with a Buy and raises the price target from $42 to $48.